Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

NCT00670319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7705

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Raloxifene HCL
DRUG: Raloxifene HCL
DRUG: Placebo

Sponsor

Eli Lilly and Company